HIGHLIGHTS
- who: Eric Macia and colleagues from the Institut de Pharmacologie Moléculaire et Cellulaire (IPMC), UMR , CNRS-Université Côte d'Azur, have published the paper: Chlortetracycline, a Novel Arf Inhibitor That Decreases the Arf6-Dependent Invasive Properties of Breast Cancer Cells, in the Journal: Molecules 2021, 969 of /2021/
- what: By screening the Prestwick chemical library for an Arf6 inhibitor, the authors focused on the tetracycline antibiotic family. The authors report the identification and the characterization of chlortetracycline (CTC) as a potent chemical inhibitor of Arf6 activity and Arf6-dependent cancer cell invasion in_vitro . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.